More men with limited life expectancy and certain localized prostate cancers have received definitive treatment over the past ...

New research from the IU School of Medicine found a discovery that could lead to new treatments for prostate cancer. The American Cancer Society said one in eight men will be ...

A team from the Institute of Cancer Research, London, found NXP800 slowed the growth of prostate cancer cells, including ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

The intended therapeutic effect of gonadotropin-releasing-hormone (GnRH) agonists is hypogonadism, which is a leading cause of osteoporosis in men. Observations are consistent with this effect ...

Jointly Bayer and Orion Corporation-developed NUBEQA (Darolutamide) + Androgen Deprivation Therapy (ADT ... patients with metastatic hormone-sensitive prostate cancer (mHSPC) and will be ...

Ahead, we’ll dig into what happens when a man is not intimately active, what intimately active really means, why you might be ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. | In this tracker, Fierce Pharma is recording the ...

Panaji:Nutri-hormonal therapy developed by the ICAR-CCARI Goa is offering a solution to one of the most persistent challenges faced by dairy farmers—repeat breeding in crossbred cows.

Cite this: The Role of Hormonal Therapy in the Management of Hormonal-Receptor-Positive Breast Cancer With Co-Expression of HER2 - Medscape - Sep 01, 2008. The article is based primarily on a ...

Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also ...